Details about the neuroanatomical projections from ORBl to ENTm

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
91842 Orbital area lateral partEntorhinal area medial part, dorsal zone lightbiotinylated dextran amine (BDA)
Labeling was observed caudally in the dorsal lateral LEC (Fig. 7D,E) and caudal part of MEC (Fig. 7F). Collator note: label in the caudalmost ENTm, Swanson parcellation scheme. The label is weak at best, with terminals concentrated in layers II-III. See Fig. 7F, Swanson Atlas Levels 46-47.
Kondo H. & Witter M.P., 2014
91856 Orbital area lateral partEntorhinal area medial part, dorsal zone not presentbiotinylated dextran amine (BDA)
Collator note: no label found in this region.
Kondo H. & Witter M.P., 2014
General description technique/protocol: In a representative case (case F-30), the BDA injection was centered in layers II–III of VLO in the middle of the orbital surface (Figs. 2, 3C, 7, Table 2). Collator note: small BDA injection in the ORBl, centrally, mapped here onto Swanson Atlas Levels 5-6.

Further details associated to record number 91842:
Position of injection: mid-rostro-caudal
Topological position of injection: is contained
Extension of injection outside: none
The injection was performed in: left hemisphere
Position of terminal field: caudal
Topological position of terminal field: is contained
Extension of terminal field outside: none
The terminal field was found: ipsilateral